SR ONE CAPITAL PARTNERS I, LP's Net Worth
$149 Million
Who is SR ONE CAPITAL PARTNERS I, LP?
SR ONE CAPITAL PARTNERS I, LP has an estimated net worth of $149 Million. This is based on reported shares across multiple companies, which include Arcellx, Inc., eFFECTOR Therapeutics, Inc., and Design Therapeutics, Inc..
SEC CIK
SR ONE CAPITAL PARTNERS I, LP's CIK is 0001853724
Past Insider Trading and Trends
2022 was SR ONE CAPITAL PARTNERS I, LP's most active year for acquiring shares with 10 total transactions. SR ONE CAPITAL PARTNERS I, LP's most active month to acquire stocks was the month of January. 2023 was SR ONE CAPITAL PARTNERS I, LP's most active year for disposing of shares, totalling 6 transactions. SR ONE CAPITAL PARTNERS I, LP's most active month to dispose stocks was the month of January. 2022 saw SR ONE CAPITAL PARTNERS I, LP paying a total of $32,574,083.00 for 6,400,007 shares, this is the most they've acquired in one year. In 2023 SR ONE CAPITAL PARTNERS I, LP cashed out on 1,621,996 shares for a total of $45,958,774.71, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Arcellx, Inc. (ACLX) Snapshot price: $64.36
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -18.42% | -1.01M |
$45.01 | -$45,589,317.35 | 4.49M |
May 11
| |||
Form 4
|
∞
| 5.5M |
$15.00 |
—
| 5.5M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
eFFECTOR Therapeutics, Inc. (EFTR) Snapshot price: $10.11
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -8.93% | -609.16K |
$0.61 | -$369,457.36 | 6.21M |
Nov 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Design Therapeutics, Inc. (DSGN) Snapshot price: $2.3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +16.00% | 900K |
$8.42 | $7,574,078.00 | 6.53M |
Dec 16 - Dec 20
| |||
Form 4
|
∞
| 5.63M |
$20.00 |
—
| 5.63M |
Mar 30
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||